Genomic Portraits: Reflections into a Tumor's Response to Therapy

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Androgen receptor signaling inhibitors (ARSI) are crucial in treating prostate cancer.
• Understanding resistance mechanisms to ARSI is vital for improving patient outcomes.
• Matched tissue specimens before and after ARSI treatment provide valuable insights.

Purpose of the Study:

• To identify unique signaling pathways and genomic signatures associated with ARSI treatment.
• To establish a comprehensive profile for guiding therapy in prostate cancer.
• To investigate the largest prospective biospecimen banking protocol for studying ARSI resistance.

Main Methods:

• Collection and annotation of matched tissue specimens from patients before and after ARSI initiation.
• Analysis of signaling pathways and genomic signatures in the collected specimens.
• Prospective biospecimen banking protocol implementation.

Main Results:

• Identification of distinct signaling pathways activated during ARSI treatment.
• Discovery of specific genomic signatures correlating with treatment response or resistance.
• Establishment of a therapeutic guidance profile based on molecular alterations.

Conclusions:

• The identified molecular profile can guide personalized therapy selection.
• Understanding resistance mechanisms is key to developing novel treatment strategies.
• This study provides a foundation for future research into ARSI resistance.